IQVIA
IQV
$235.00
Share price
0.56%
Change (1 day)
22.90%
Change (1 year)
IQVIA (IQV) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $20.23 B
According to IQVIA's latest financial reports the company's total liabilities are $20.23 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
IQVIA - Total liabilities on balance sheet (from 2012 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $20.56 B | 5.09% |
| 2022-12-31 | $19.57 B | 4.96% |
| 2021-12-31 | $18.64 B | 1.99% |
| 2020-12-31 | $18.28 B | 7.63% |
| 2019-12-31 | $16.98 B | 8.93% |
| 2018-12-31 | $15.59 B | 6.72% |
| 2017-12-31 | $14.61 B | 18.34% |
| 2016-12-31 | $12.34 B | 189.72% |
| 2015-12-31 | $4.26 B | 6.55% |
| 2014-12-31 | $3.99 B | 7.11% |
| 2013-12-31 | $3.73 B | -3.21% |
| 2012-12-31 | $3.85 B | 17.18% |
| 2011-12-31 | $3.29 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $3.14 M | -99.98% | Bahamas |
 NRC Health
NRC | $73.48 M | -99.64% | 🇺🇸 USA |